At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures: Does it Increase Blood Loss and Interventions for Blood Loss and Why Do Anesthesiologists Choose to Use It?
In Brief
A Phase 4 clinical trial evaluating Sevoflurane and No Sevoflurane for Blood Loss and Anesthesia. Completed, enrolled 160 participants across 2 sites.
Detailed Summary
Sevoflurane is an FDA-approved anesthetic drug commonly used for anesthesia during second trimester abortion procedures. It has a few advantages, including ease of use by the anesthesia provider. However, the literature suggests that when used in doses higher than those used at Oregon Health \& Science University (OHSU) and Lovejoy, it is associated with an increase in the risk of bleeding. The investigators study aims to test whether the lower dose used at OHSU and Lovejoy during second trimester abortion procedures causes any difference in blood loss, when compared to similar abortion procedures for which this drug is not used.
Study Details
Timeline
Interventions
Subject receives Sevoflurane in addition to other standard of care drug regimens for anesthesia with this procedure.
Subject only standard of care drug regimens for anesthesia with this procedure.